东亚药业：8月28日召开董事会会议

Group 1 - East Asia Pharmaceutical held its fourth board meeting on August 28, 2025, to review the semi-annual report and its summary [1] - For the year 2024, East Asia Pharmaceutical's revenue composition was 99.19% from pharmaceutical chemicals and 0.81% from other businesses [1] - As of the report, East Asia Pharmaceutical has a market capitalization of 2.3 billion yuan [1]